Brian Kim, MBA, the chief executive officer of Mission Bio, also discussed the company’s plans for collaboration.
Brian Kim, MBA
Advertisement
Articles by Brian Kim, MBA
Brian Kim, MBA, the chief executive officer of Mission Bio, discussed the company’s single cell assay platform in the context of the broader developing field cell and gene therapy field.
The CEO of Mission Bio also discussed the company’s plans for collaboration.
Brian Kim, MBA, on Multiomic Single-Cell Sequencing and the Ebbs and Flows of the Gene Therapy Field
The CEO of Mission Bio discussed the company’s single cell assay platform in the context of the broader developing field cell and gene therapy field.
Brian Kim, MBA, the chief executive officer of Mission Bio, discussed the company’s Tapestri platform for single cell sequencing.
The CEO of Mission Bio discussed the company’s Tapestri platform for single cell sequencing.
Advertisement
Latest Updated Articles
The Emergence of CRISPR-Based Medicines and the Resurgence of AAVPublished: June 22nd 2025 | Updated:
- Multiomic Single-Cell Sequencing and the Ebbs and Flows of the Gene Therapy Field
Published: June 19th 2025 | Updated:
Brian Kim, MBA, on the Emergence of CRISPR-Based Medicines and the Resurgence of AAVPublished: May 21st 2025 | Updated:
- Brian Kim, MBA, on Multiomic Single-Cell Sequencing and the Ebbs and Flows of the Gene Therapy Field
Published: May 17th 2025 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
M. Peter Marinkovich, MD, on Integrating Gene Therapy into Clinical Practice for Dermatologists
2
Quarter Century Update: How can Partnerships Between Academia, Biotech, and Pharma be Better Structured?
3
Quarter Century Update: The Continued Unknowns of Cell and Gene Therapy
4
